Premium
Safety concerns of sodium‐glucose co‐transporter‐2 inhibitors in type 1 diabetes: A real‐world study from the perspective of the Food and Drug Administration Adverse Event Reporting System
Author(s) -
Zhou Xiang,
Zhou Yangzhong,
Li Xuemei,
Xiao Xinhua
Publication year - 2020
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/dom.14138
Subject(s) - medicine , beijing , china , family medicine , political science , law